
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
BNNn | Xetra | EUR | Delayed | |
BNNn | Frankfurt | EUR | Delayed | |
BNNn | TradeGate | EUR | Delayed |
BRAIN Biotech AG provides bio-based products and solutions in Germany, the United States, France, the Netherlands, and the United Kingdom. It operates through three segments: BioProducts, BioScience, and BioIncubator. The company offers enzymes, biocatalysts, microorganisms, and other bioactive natural compounds to produce foodstuffs and animal feed, cosmetics, and medical products, as well as for industrial applications in chemical companies, waste and hazardous materials disposal, and energy and raw materials production. The company was formerly known as B.R.A.I.N. Biotechnology Research and Information Network AG and changed its name to BRAIN Biotech AG in April 2021. The company was founded in 1993 and is headquartered in Zwingenberg, Germany.
Name | Age | Since | Title |
---|---|---|---|
Anna Carina Eichhorn | 53 | 2017 | Vice Chairwoman of the Supervisory Board |
Michael Majerus | 64 | 2019 | Independent Chairman of the Supervisory Board |
Stephen Catling | - | 2020 | Independent Member of Supervisory Board |
Florian Schnabel | 55 | 2023 | Supervisory Board Member |
Christine Uekert | 61 | 2023 | Independent Supervisory Board Member |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review